Tieman Joins Higginbotham’s Life Sciences Insurance Unit

September 2, 2009

Higginbotham & Associates, a national independent insurance brokerage firm with Texas statewide offices, appointed Kay Kirk Tieman senior account executive for its Life Sciences Risk and Insurance Practice.

Working from Higginbotham’s Denton office, she will apply her 25 years of sales and marketing experience concentrated in the health care and life sciences industries to strengthen the firm’s production in the biotechnology and medical devises sector.

Higginbotham’s Life Sciences Risk and Insurance Practice is led by commercial property/casualty insurance brokers Ed Coker and Matt Heinzelmann. They launched the practice in 2005 to meet the highly specialized risk management needs of life sciences research, manufacturing and distribution companies.

Tieman began her career in in Massachusetts with American Cystoscope Makers. She started in sales with American Scientific Products and later became a district manager for Critical Care America, a national home infusion therapy company.

She transitioned into business/corporate development when she worked for the Massachusetts Biotech Council (MBC) and later for the Biotech Industry Organization (BIO) in Washington, DC. During her tenure, Tieman founded the first Group Purchasing Organization (GPO) for biotechnology in the New England region, which she expanded nationally under the BIO umbrella (www.biobusinessolutions.com).

Tieman subsequently served as senior director of technology business development for the Greater Dallas Chamber of Commerce, where she oversaw programming and business development for the chamber’s Technology Business Council and Life Sciences Committee. Tieman formed the first partnership between Dallas and Fort Worth life sciences constituents, laying the foundation for BioDFW, a regional life sciences alliance.

She was vice president of marketing for Swearingen Realty Group just prior to joining Higginbotham.

Source: Higginbotham & Associates Inc., www.higginbotham.net

Was this article valuable?

Here are more articles you may enjoy.